Finance

Lists
Why is TRDA up ၉.၃၀%?
Dive Deeper
TRDA:NASDAQ
Entrada Therapeutics Inc
၄.၈၂ US$
+၉.၃၀%
(+၀.၄၁) 1D
အောက် ၂၆, GMT-၄ ၁၄:၅၆:၁၇  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TRDA...
Open
၄.၅၂ US$
High
၄.၉၄ US$
Low
၄.၄၆ US$
Mkt. cap
၁၈.၇၇ ကုဋေ
Avg. vol.
၃.၅၂ သိန်း
Volume
၃.၆၇ သိန်း
52-wk high
၁၆.၄၅ US$
52-wk low
၄.၁၁ US$
EPS
-၃.၉၇ US$
Beta
-၀.၂၄
Shares outstanding
၃.၈၉ ကုဋေ
No. of employees
၁၅၂
Open
၄.၅၂ US$
High
၄.၉၄ US$
Low
၄.၄၆ US$
Mkt. cap
၁၈.၇၇ ကုဋေ
Avg. vol.
၃.၅၂ သိန်း
Volume
၃.၆၇ သိန်း
52-wk high
၁၆.၄၅ US$
52-wk low
၄.၁၁ US$
EPS
-၃.၉၇ US$
Beta
-၀.၂၄
Shares outstanding
၃.၈၉ ကုဋေ
No. of employees
၁၅၂
News stories
From web sources and news partners
Investor's Business Daily
Investor's Business Daily
·
ပြီးခဲ့သည့် ၈ မိနစ်
Boeing Losses Expected To Narrow. Defense Awards, 737 Certification, Deliveries In Focus.
The Motley Fool
The Motley Fool
·
ပြီးခဲ့သည့် ၁၁ မိနစ်
Why Investing in S&P 500 Index Funds Is a Whole Lot Riskier These Days
The Business Journals
The Business Journals
·
ပြီးခဲ့သည့် ၂၂ မိနစ်
Clayton-based road materials firm scraps stock offering tied to Nasdaq push, keeps listing goal
SEC.gov
SEC.gov
·
ပြီးခဲ့သည့် ၅ နာရီ
Anthropic, PBC - S-1 (Q2)
About Entrada Therapeutics Inc
CEO-
Employees၁၅၂
Founded၂၀၁၆
Headquartersဘော့စတွန်မြို့, မက်ဆာချူးဆက်ပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Analyst ratings
Based on 5 analysts giving stock ratings to TRDA in the past 3 months
Strong buy
Buy
4
Hold
1
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for TRDA in the last 3 months.
Highest
Current ၄.၈၂ US$
၂၅.၀၀ US$ (+၄၁၈.၆၇%)
Average
၁၉.၆၇ US$ (+၃၀၈.၀၉%)
Lowest
၁၁.၀၀ US$ (+၁၂၈.၂၂%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ram Selvaraju
H.C. Wainwright
Hold
Reiterated
-
-
10/19/2026
Jonathan Miller
Evercore ISI
Buy
Maintained
၂၅.၀၀ US$
+၄၁၈.၇%
10/15/2026
Kostas Biliouris
Oppenheimer
Buy
Reiterated
၂၃.၀၀ US$
+၃၇၇.၂%
09/03/2026
Boobalan Pachaiyappan
Roth MKM
Buy
Reiterated
၁၁.၀၀ US$
+၁၂၈.၂%
08/12/2026
Myles Minter
William Blair
Buy
Maintained
-
-
08/05/2026
Debjit Chattopadhyay
Guggenheim
Buy
Maintained
၁၇.၀၀ US$
+၂၅၂.၇%
06/05/2026
Joseph Thome
TD Cowen
Buy
Maintained
-
-
05/07/2026
Yanni Souroutzidis
Cantor Fitzgerald
Buy
Initiated
-
-
04/01/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
၁.၆၁ သန်း
၁.၃၀ သန်း
၈.၇၅ သိန်း
၈.၉၈ သိန်း
Cost of goods sold
၃.၈၄ ကုဋေ
၃.၂၃ ကုဋေ
၃.၃၁ ကုဋေ
၃.၅၄ ကုဋေ
Cost of revenue
၃.၈၄ ကုဋေ
၃.၂၃ ကုဋေ
၃.၃၁ ကုဋေ
၃.၅၄ ကုဋေ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၁.၀၃ ကုဋေ
၉.၃၅ သန်း
၁.၀၁ ကုဋေ
၁.၀၅ ကုဋေ
Operating expense
၁.၀၃ ကုဋေ
၉.၃၅ သန်း
၁.၀၁ ကုဋေ
၁.၀၅ ကုဋေ
Total operating expenses
၄.၈၇ ကုဋေ
၄.၁၆ ကုဋေ
၄.၃၂ ကုဋေ
၄.၅၉ ကုဋေ
Operating income
-၄.၇၁ ကုဋေ
-၄.၀၃ ကုဋေ
-၄.၂၃ ကုဋေ
-၄.၅၀ ကုဋေ
Other non operating income
-
-
-
-
EBT including unusual items
-၄.၃၅ ကုဋေ
-၃.၉၁ ကုဋေ
-၃.၉၇ ကုဋေ
-၄.၂၇ ကုဋေ
EBT excluding unusual items
-၄.၃၅ ကုဋေ
-၃.၇၂ ကုဋေ
-၃.၉၇ ကုဋေ
-၄.၂၇ ကုဋေ
Income tax expense
၆.၅၄ သိန်း
၉.၂၀ သောင်း
၃.၈၀ သောင်း
၃.၅၀ သောင်း
Effective tax rate
-၁.၅၀%
-၀.၂၄%
-၀.၁၀%
-၀.၀၈%
Other operating expenses
-
-
-
-
Net income
-၄.၄၁ ကုဋေ
-၃.၉၂ ကုဋေ
-၃.၉၇ ကုဋေ
-၄.၂၈ ကုဋေ
Net profit margin
-၂,၇၃၄.၄၅%
-၃,၀၁၄.၉၃%
-၄,၅၃၉.၀၉%
-၄,၇၆၂.၀၃%
Earnings per share
-၁.၀၆
-၀.၉၄
-၀.၉၅
-၁.၀၁
Interest and investment income
၃.၅၇ သန်း
၃.၁၄ သန်း
၂.၆၂ သန်း
၂.၂၄ သန်း
Interest expense
-
-
-
-
Net interest expenses
၃.၅၇ သန်း
၃.၁၄ သန်း
၂.၆၂ သန်း
၂.၂၄ သန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
-၄.၅၈ ကုဋေ
-၃.၉၄ ကုဋေ
-၄.၁၅ ကုဋေ
-၄.၄၁ ကုဋေ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google အက်ပ်များ